Analysis of Severe and Critical COVID-19 Patients Treated With Favipiravir: A Retrospective Cohort Study

Journal Title: Hamidiye Medical Journal - Year 2021, Vol 2, Issue 1

Abstract

Background: We aimed to analyze demographic characteristics, smoking status, comorbidities, laboratory parameters and other treatments before favipiravir use in severe to critically ill patients with coronavirus disease-2019 (COVID-19) who were treated with favipiravir in Turkey. Materials and Methods: This study was conducted as a retrospective observational study in a tertiary reference hospital for COVID-19. Clinical and laboratory data of COVID-19 patients who were consecutively treated with favipiravir were evaluated. The patients were divided into two groups as survivors and non-survivors. Results: The mean ages of the non-survivors and survivors were 67.3±13.3 and 57.3±16.4 years (p<0.0001), respectively. The smoking rate was 44.4% in non-survivor group and 9.1% in the survivor group (p=0.01). Older age [odds ratio (OR): 1.04, 95% confidence interval (CI): 1.016-1.069], smoking (OR: 5.76, 95% CI: 1.84-18.03), presence of one or more comorbidity (OR: 4.43, 95% CI: 1.79-10.91), coronary artery disease (CAD) (OR: 2.66, 95% CI: 1.06-6.72), arrhythmia (OR: 3.4, 95% CI: 1.78-9.82) and congestive heart failure (CHF) (OR: 14.4, 95% CI: 2.9-71.43) were significantly related to mortality (p<0.05). The rate of patients who were treated with lopinavir/ritonavir before favipiravir was higher in the non-survivor group (p=0.0001). Favipiravir treatment was started earlier in survivors than in non-survivors (3.1±2.2 and 4.7±3.4 days, respectively, p=0.006). Conclusion: Older age, smoking, presence of one or more comorbidity, CAD, arrhythmia, CHF and treatment with lopinavir/ritonavir before favipiravir were associated with mortality. Favipiravir was started earlier in survivors. Oxygen saturation levels and platelet count increased, and C-reactive protein (CRP) and lactate dehydrogenase levels decreased with favipiravir treatment in survivors. Higher CRP levels were also associated with mortality.

Authors and Affiliations

Bengü Şaylan, Tayfun Çalışkan

Keywords

Related Articles

Deep Neck Space Infection: Clinical Outcomes of Patients Treated in a Tertiary Care Center

Background: Deep neck space infection (DNSI) is a suppurative infection of the visceral cavities of the neck, which usually begins in the form of fasciitis and progresses to abscess formation. Immediate evaluation and ma...

Assessment of the Functional Health Status of Hypertension Patients in Family Medicine

Background: In this study, it was aimed to evaluate the functional health status of hypertensive patients and to determine the factors affecting their functional health status. Materials and Methods: This is a single-ce...

A Study of HIV Knowledge and Stigma Among Health Care Workers from Istanbul-Turkey

Background: Human immunodeficiency virus (HIV) is a global public health problem affecting over 38 million people. While the yearly number of new cases is reducing in the world, this number is increasing in our country....

Ocular Findings and Multimodal Imaging Characteristics of Retinitis Pigmentosa Patients

Background: To investigate the ocular findings and multimodal imaging characteristics of retinitis pigmentosa (RP) patients. Materials and Methods: Patients who were followed up in our clinic for RP were evaluated retro...

Effects of Smoking on Acute Hypobaric Hypoxia Tolerance

Background: Smoking may impair oxygen transport ability of blood and airway destructions might be seen in long term smokers. After 1-3 cigarette smoking, it leads to a rise in carboxyhemoglobin level in blood, and it has...

Download PDF file
  • EP ID EP693721
  • DOI 10.4274/hamidiyemedj.galenos.2021.29591
  • Views 131
  • Downloads 0

How To Cite

Bengü Şaylan, Tayfun Çalışkan (2021). Analysis of Severe and Critical COVID-19 Patients Treated With Favipiravir: A Retrospective Cohort Study. Hamidiye Medical Journal, 2(1), -. https://europub.co.uk/articles/-A-693721